OpenEvidence Secures $210M at $3.5B Valuation to Enhance AI-Driven Medical Search and Decision-Making Tools

OpenEvidence Inc., a healthcare AI platform, has secured $210 million in funding, achieving a $3.5 billion valuation. Founded in 2021, the company aims to revolutionize clinician access to real-time medical knowledge through an AI-powered decision-support platform. This platform utilizes peer-reviewed medical literature from sources like the Journal of the American Medical Association, ensuring that clinicians receive evidence-based insights rapidly. OpenEvidence’s clinician-focused AI search tool offers tailored, referenced answers to patient-specific questions, improving efficiency in high-pressure situations. The platform, HIPAA-compliant, is widely adopted, serving over 10,000 hospitals and 40% of American physicians. Key partnerships with major medical publishers enhance content quality, addressing the challenges of clinician burnout and a projected physician shortfall. OpenEvidence also introduced DeepConsult, an AI assistant designed to help physicians manage research tasks, reinforcing their commitment to improving healthcare outcomes. Investors include Google Ventures and Sequoia Capital.

Source link